Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Arcadia Biosciences (RKDA) Misses Q3 EPS by $1.27
November 6, 2019 5:37 PM ESTArcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($2.04), $1.27 worse than the analyst estimate of ($0.77). Revenue for the quarter came in at $392 thousand versus the consensus estimate of $290 thousand.
"We achieved important progress during the third quarter in both product commercialization and continuing research and development in each of our three strategic crop categories hemp, wheat and soy," said Matthew Plavan, president and CEO. "We continue to lay the foundations for rapid revenue growth, across multiple product lines in 2020 and beyond, with notable acceleration... More
